Related Experiment Video
Updated: Jun 10, 2026
06:22
Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Is there a link between glucose levels and heart failure? An update
Arnaldo Schainberg1, Antônio Ribeiro-Oliveira, José Marcio Ribeiro
1Hospital Governador Israel Pinheiro, Instituto de Previdência dos Servidores do Estado de Minas Gerais, Departamento de Endocrinologia, Belo Horizonte, MG, Brazil.
Arquivos Brasileiros De Endocrinologia E Metabologia
|August 10, 2010
Summary
Diabetes increases cardiovascular risk, with hyperglycemia independently worsening heart failure (HF). This review examines hyperglycemia's role in HF progression among diabetic individuals.
Area of Science:
- Cardiology
- Endocrinology
- Diabetology
Background:
- Diabetes mellitus is linked to a higher prevalence of cardiovascular disease (CVD).
- Hyperglycemia, a key feature of diabetes, is increasingly recognized for its independent contribution to cardiovascular complications.
- Heart failure (HF) is a common and serious manifestation of CVD in diabetic populations.
Purpose of the Study:
- To review current data on the natural course of CVD in individuals with diabetes.
- To elucidate the specific role of hyperglycemia in the pathogenesis and progression of heart failure.
- To highlight the limited interventional trial data on glucose-lowering strategies and cardiovascular outcomes.
Main Methods:
- Review of epidemiological studies and population datasets.
- Analysis of existing literature on hyperglycemia and its impact on cardiac function.
- Synthesis of data from interventional trials concerning glucose-lowering therapies and cardiovascular events.
Main Results:
- Epidemiological data strongly suggest hyperglycemia independently contributes to HF risk.
- Studies indicate hyperglycemia plays a pathogenic role in left ventricular dysfunction and HF progression.
- Evidence from interventional trials on the effect of glucose-lowering on CV outcomes in HF is currently limited.
Conclusions:
- Hyperglycemia is a significant, independent risk factor for heart failure in diabetic patients.
- Understanding hyperglycemia's role is crucial for managing cardiovascular disease in diabetes.
- Further interventional research is needed to clarify the benefits of glucose-lowering strategies on cardiovascular outcomes in HF.
Related Concept Videos
01:27Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
01:30Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:02Glucose Homeostasis: Regulation of Blood Glucose
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...